Jean-Daniel Lalau
7PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 12, 2022
A comment on metformin and COVID-19 with regard to "Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy".Abdallah Al-Salameh, Nicolas Wiernsperger, Bertrand Cariou
|Sep 21, 2021
Pharmacodynamics and pharmacokinetics of extended-release metformin in patients with type 2 diabetes and chronic kidney disease stage 3B.Jean-Daniel Lalau, Youssef Bennis, Abdallah Al-Salameh
|Jan 07, 2018
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4.Jean-Daniel Lalau, Farshad Kajbaf, Youssef Bennis
|Apr 19, 2017
Metformin-associated lactic acidosis (MALA): Moving towards a new paradigm.Jean-Daniel Lalau, Farshad Kajbaf, Alessandro Protti
|Jan 15, 2015
Interpreting the consequences of metformin accumulation in an emergency context: impact of the time frame on the blood metformin levels.Jean-Daniel Lalau, Farshad Kajbaf
|Dec 09, 2014
Eating disorders in schizophrenia: implications for research and management.Youssef Kouidrat, Ali Amad, Jean-Daniel Lalau
Pageof 2
